Clinical Trials · NCT06468748

The Effects of Semaglutide on Body Composition and Performance in Military Personnel

WithdrawnPhase 4Semaglutide (Prohibited)
Phase
Phase 4
Recruitment status
Withdrawn
Sponsor
United States Army Research Institute of Environmental Medicine
Enrollment
0
Start date
Aug 2024
Locations
1 site, United States
Primary endpoint
Weight Loss
View Semaglutide compound reference